Stock Events

Stock Events

Astrazeneca 

$181.24
5929
-$2.22-1.21% Tuesday 20:00

Statistics

Day High
181.96
Day Low
180
52W High
209.48
52W Low
66.23
Volume
2,339,525
Avg. Volume
-
Mkt Cap
0
P/E Ratio
27.86
Dividend Yield
1.76%
Dividend
3.18

Upcoming

6
AUG
Dividend Ex
Estimated
 
8
SEP
Dividend Payment
Estimated
 
22
FEB 27
Dividend Ex
Estimated
 
23
MAR 27
Dividend Payment
Estimated
 
9
AUG 27
Dividend Ex
Estimated
 

Dividends

1.76%Dividend Yield
Mar 26
$2.15
Sep 25
$1.03
Mar 25
$2.13
Sep 24
$0.99
Mar 24
$1.98
10Y Growth
0.56%
5Y Growth
2.46%
3Y Growth
3.55%
1Y Growth
0.7%

Earnings

27JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.07
2.24
2.41
2.58
Expected EPS
2.490975
Actual EPS
N/A

Financials

17.41%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
117.48BRevenue
20.45BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AZN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a direct competitor in various therapeutic areas including oncology, vaccines, and cardiovascular health, similar to AstraZeneca's portfolio.
Merck
MRK
Mkt Cap277.02B
Merck & Co. competes closely with AstraZeneca, especially in the oncology sector with its leading cancer treatments.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in areas like immunology and oncology.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with AstraZeneca in respiratory diseases, oncology, and vaccine development.
Novartis
NVS
Mkt Cap279.67B
Novartis competes across several of the same therapeutic areas as AstraZeneca, including cardiovascular, oncology, and respiratory.
Roche
RHHBY
Mkt Cap328.49B
Roche, with its strong portfolio in oncology and diagnostics, is a major competitor, especially in cancer treatment.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb competes in the oncology space, particularly with its range of cancer therapies.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with AstraZeneca in areas such as diabetes, cardiovascular diseases, and vaccines.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, with its biopharmaceutical focus, competes in immunology and oncology, similar to AstraZeneca's research areas.
AMGEN
AMGN
Mkt Cap178B
Amgen's focus on biologic medicines in areas like oncology and cardiovascular disease places it as a competitor to AstraZeneca.

About

There is no Profile data available for ZEG.SG.
Show more...
CEO
Mr. Pascal Claude Roland Soriot D.V.M., M.B.A.
Employees
94300
Country
United Kingdom
ISIN
GB0009895292

Listings

MX
MX
AZN1N.MX
XNYS
US
AZN
OTCM
US
AZNCF
SA
BR
A1ZN34.SA

0 Comments

Share your thoughts

FAQ

What is Astrazeneca stock price today?▼
The current price of AZN is $181.24 USD — it has decreased by -1.21% in the past 24 hours. Watch Astrazeneca stock price performance more closely on the chart.
What is Astrazeneca stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Astrazeneca stocks are traded under the ticker AZN.
Is Astrazeneca stock price growing?▼
AZN stock has fallen by -2.14% compared to the previous week, the month change is a -10.64% fall, over the last year Astrazeneca has showed a +157.96% increase.
When is the next Astrazeneca earnings date?▼
Astrazeneca is going to release the next earnings report on July 27, 2026.
What were Astrazeneca earnings last quarter?▼
AZN earnings for the last quarter are 2.58 USD per share, whereas the estimation was 2.52 USD resulting in a +2.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Astrazeneca revenue for the last year?▼
Astrazeneca revenue for the last year amounts to 117.48B USD.
What is Astrazeneca net income for the last year?▼
AZN net income for the last year is 20.45B USD.
Does Astrazeneca pay dividends?▼
Yes, AZN dividends are paid semi-annual. The last dividend per share was 2.15 USD. As of today, Dividend Yield (FWD)% is 1.76%.
How many employees does Astrazeneca have?▼
As of May 06, 2026, the company has 94,300 employees.
In which sector is Astrazeneca located?▼
Astrazeneca operates in the Health & Wellness sector.
When did Astrazeneca complete a stock split?▼
The last stock split for Astrazeneca was on July 27, 2015 with a ratio of 2:1.
Where is Astrazeneca headquartered?▼
Astrazeneca is headquartered in Cambridge, United Kingdom.